APOE and Alzheimer disease: In addition, FHS subjects had a higher average CRP level (2.2 mg/L vs. 1.4 mg/L), lower APOE ε4 carrier frequency (21.9% vs. 24.2%), and higher proportion of individuals with AD (5% vs. 0.3%) than UKBB subjects.